JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


Anesth Analg 2008; 106:1410-1413
© 2008 International Anesthesia Research Society
doi: 10.1213/ane.0b013e31816091f0
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grecu, L.
Right arrow Articles by Rosow, C. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grecu, L.
Right arrow Articles by Rosow, C. E.
Related Collections
Right arrow Ambulatory
Right arrow Complications
Right arrow Clinical Pharmacology
Right arrow Pharmacology


AMBULATORY ANESTHESIOLOGY

Haloperidol Plus Ondansetron Versus Ondansetron Alone for Prophylaxis of Postoperative Nausea and Vomiting

Loreta Grecu, MD*, Edward A. Bittner, MD, PhD*, Jay Kher, MD{dagger}, Sarah E. Smith, BS{ddagger}, and Carl E. Rosow, MD, PhD*

From the *Department of Anesthesia and Critical Care, Massachusetts General Hospital; {dagger}Tufts New England Medical Center; and {ddagger}Boston University School of Medicine, Boston, Massachusetts.

Address correspondence to Carl Rosow, MD, PhD, Department of Anesthesia and Critical Care, Massachusetts General Hospital, 55 Fruit St., Boston, MA 02114. Address e-mail to crosow{at}partners.org.

Abstract

INTRODUCTION: Haloperidol 1 mg and ondansetron 4 mg are equally safe and effective for postoperative nausea and vomiting prophylaxis. We compared the combination to ondansetron alone in a mixed surgical population.

METHODS: Two-hundred and sixty-eight adults undergoing general anesthesia received 4 mg ondansetron plus 1 mg haloperidol or saline in this randomized, double-blind protocol. Efficacy and safety data were obtained until 480 min after postanesthesia care unit entry.

RESULTS: The combination had more complete responders (76.2% vs 59.2%), less nausea, less rescue, and longer time to rescue. Sedation, time to postanesthesia care unit discharge, and QTc prolongation were not different. No subject had dystonia, akathisia, or serious dysrhythmias.

CONCLUSIONS: Postoperative nausea and vomiting prophylaxis with both drugs is significantly more effective and longer lasting than ondansetron alone. There is no detectable increase in side effects.




This article has been cited by other articles:


Home page
Anesth. Analg.Home page
A. S. Habib and T. J. Gan
Haloperidol for Postoperative Nausea and Vomiting: Are We Reinventing the Wheel?
Anesth. Analg., May 1, 2008; 106(5): 1343 - 1345.
[Full Text] [PDF]


Home page
Anesth. Analg.Home page
D. B. Ludwin and S. L. Shafer
CON: The Black Box Warning on Droperidol Should Not Be Removed (But Should Be Clarified!)
Anesth. Analg., May 1, 2008; 106(5): 1418 - 1420.
[Full Text] [PDF]




Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins and Stanford University Libraries' HighWire Press®. Copyright 2008 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2008 by the International Anesthesia Research Society.